Cell Source Inc (CLCS)
OTHER OTC:CLCS
US Market
Holding CLCS?
Track your performance easily

Cell Source (CLCS) Financial Statements

10 Followers

Cell Source Financial Overview

Cell Source's market cap is currently ―. The company's EPS TTM is $-0.162; its P/E ratio is -3.24; Cell Source is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.49M$ -1.28M$ -4.74M$ -995.38K$ -1.24M
EBITDA$ -1.49M$ -1.28M$ -4.74M$ -995.38K$ -1.24M
Net Income Common Stockholders$ -1.83M$ -1.60M$ -1.37M$ -1.65M$ -1.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 90.55K$ 23.00$ 22.20K$ 2.58K$ 21.99K
Total Assets$ 429.77K$ 82.59K$ 195.17K$ 248.36K$ 362.33K
Total Debt$ 343.53K$ 22.03K$ 42.03K$ 130.04K$ 321.50K
Net Debt$ 252.98K$ 22.01K$ 19.83K$ 127.46K$ 299.51K
Total Liabilities$ 17.75M$ 3.26M$ 2.53M$ 16.28M$ 15.31M
Stockholders Equity$ -17.32M$ -16.75M$ -15.61M$ -16.03M$ -14.95M
Cash Flow-
Free Cash Flow$ -1.12M$ -173.85K$ -722.29K$ -279.97K$ -1.04M
Operating Cash Flow$ -1.12M$ -173.85K$ -722.29K$ -279.97K$ -1.04M
Investing Cash Flow-----
Financing Cash Flow$ 1.21M$ 151.67K$ 741.91K$ 260.56K$ 925.00K
Currency in USD

Cell Source Earnings and Revenue History

Cell Source Debt to Assets

Cell Source Cash Flow

Cell Source Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis